Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
Titel:
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
Auteur:
Fasching, Peter A. Hein, Alexander Kolberg, Hans-Christian Häberle, Lothar Uhrig, Sabrina Rübner, Matthias Belleville, Erik Hack, Carolin C. Fehm, Tanja N. Janni, Wolfang Hartmann, Arndt Erber, Ramona Theuser, Anna-Katharin Brucker, Sara Y. Hartkopf, Andreas D. Untch, Michael